| 期 |
标题 |
文件 |
| 卷 32, 编号 3 (2025) |
Pharmacoepidemiological characteristics of antibacterial drug prescriptions used in patients with exacerbation of chronic pyelonephritis in real-life practice in Kursk and Chisinau |
|
|
Povetkin S., Kornilov A., Levashova O., Zhilyaeva Y., Bachinsky N., Podgurski L., Tsurkan L., Golovach I.
|
| 卷 31, 编号 1 (2024) |
Phenotype of bronchial asthma with fixed obstruction |
|
|
Kostina E., Trushina E., Tipikin V., Orlova E.
|
| 卷 30, 编号 4/5 (2023) |
Polycystic ovary syndrome phenotypes |
|
|
Pustotina O.
|
| 卷 32, 编号 2 (2025) |
Pheochromocytoma in an elderly patient (case report) |
|
|
Khamnueva L., Andreeva L., Gryaznova M., Danilova E., Basayeva A.
|
| 卷 32, 编号 4 (2025) |
Atrial fibrillation and atrial flutter: diagnosis and therapy |
|
|
Cherniaeva M., Esina E., Sizova O.
|
| 卷 30, 编号 1/2 (2023) |
Atrial fibrillation and anemia: what do we know and how to approach therapy? |
|
|
Polyakova O., Dubinina A., Telkova S., Isaakyan Y., Ostroumova O.
|
| 卷 32, 编号 5 (2025) |
Physiotherapeutic approach in the treatment of rosacea. Modern approaches to the treatment of rosacea through the prism of pathogenesis |
|
|
Khanalieva I., Svechnikova E., Gladko V., Izmaylova I.
|
| 卷 32, 编号 6 (2025) |
Physical properties of surfactant as a basis for its effectiveness in the experiment |
|
|
Mostovoi A., Karpova A., Burenkov R., Ermolinsky P., Lugovtsov A., Vorobyeva S., Sinitsa D., Igina I., Nekhoroshkin S., Volodin N.
|
| 卷 31, 编号 1 (2024) |
Filaggrin as a biomarker of exacerbation of atopic dermatitis during pregnancy |
|
|
Kandrashkina Y., Orlova E., Levashova O., Kostina E.
|
| 卷 30, 编号 13 (2023) |
Phototechnologies in the treatment of melasma |
|
|
Semizidis A., Manturova N.
|
| 卷 30, 编号 3 (2023) |
The functional state of the thyroid gland in patients with end-stage renal disease on program hemodialysis |
|
|
Allamova G., Dygun O., Lukichev B., Belyakova L., Mikheeva Y., Volkova A.
|
| 卷 30, 编号 1/2 (2023) |
The nature of congenital anomalies of the urinary system in children with undifferentiated connective tissue dysplasia |
|
|
Dlin V., Kuznetsova T., Dlin S.
|
| 卷 30, 编号 9/10 (2023) |
Characterization of the plasminogen activator inhibitor type 1 gene (PAI-1) and its role in the development of arterial thrombosis |
|
|
Izmozherova N., Popov A., Antropova I., Kadnikov L., Polyanok A., Ispavsky V.
|
| 卷 32, 编号 6 (2025) |
Characteristics of clinical phenotypes of atopic dermatitis in pregnant women |
|
|
Kandrashkina Y., Orlova E.
|
| 卷 32, 编号 1 (2025) |
Chronic pain and sleep disorders |
|
|
Kotova O., Belyaev A., Melik-Arakelyan S.
|
| 卷 32, 编号 6 (2025) |
Chronic migraine: diagnosis and treatment |
|
|
Filatova E.
|
| 卷 32, 编号 4 (2025) |
Chronic morphologically verified gastritis, variants of course |
|
|
Plotnikova E., Kutsaeva A., Sukhikh A., Baranova E., Sinkov M., Nikonorova M.
|
| 卷 30, 编号 1/2 (2023) |
Chronic functional constipation in young and middle age patients: delicate problem – delicate decision |
|
|
Trukhan D., Rozhkova M., Goloshubina V.
|
| 卷 30, 编号 11 (2023) |
Ceritinib in the treatment of ALK-positive non-small cell lung cancer |
|
|
Gordeeva O., Ivanova K., Meshcheryakov A.
|
| 卷 32, 编号 3 (2025) |
Cefixime in the treatment of urinary tract infections: modern possibilities in urological and gynecological practice |
|
|
Editorial T.
|
| 卷 31, 编号 4 (2024) |
Frequency and spectrum of PIK3CA mutations in hormone-dependent HER2-negative breast cancer: a single-center experience |
|
|
Romashkina N., Klishina M., Karabina E.
|
| 卷 32, 编号 1 (2025) |
What do urban and rural residents know about the importance of taking vitamin D (using the Astrakhan region as an example) |
|
|
Sagitova G., Antonova A., Davydova O., Zykova A., Sereda V.
|
| 卷 31, 编号 6 (2024) |
Health schools as a method of infectious disease prevention in patients with chronic somatic pathology |
|
|
Moiseeva M., Mordyk A., Bagisheva N., Shapran A., Shcherbakova L., Mordyk D.
|
| 卷 32, 编号 7 (2025) |
Ezetimibe in the treatment of dyslipidemia in children and adolescents with types 1 and 2 diabetes mellitus: efficacy and safety |
|
|
Pshenichnikova I., Zakharova I., Borzakova S., Pupykina V., Osmanov I.
|
| 卷 30, 编号 6/7 (2023) |
Pelvic extrusion in patients with cervical cancer: clinical experience |
|
|
Khakimov G., Khakimova G., Musurmonov K., Khakimova S., Orifjonova G.
|
| 卷 30, 编号 14 (2023) |
Endovascular treatment of a patient with chronic abdominal ischemia syndrome: a clinical case |
|
|
Bykova E., Zakharova O., Platonava N.
|
| 卷 32, 编号 7 (2025) |
Endotypic heterogeneity of chronic rhinosinusitis |
|
|
Krasilnikova S., Gorbunova K., Eliseeva T., Bulgakova V.
|
| 卷 31, 编号 1 (2024) |
Epidemiological characteristics of respiratory infections during the last autumn-winter season of the COVID-19 pandemic according to data from a repurposed children’s hospital |
|
|
Zaytseva O., Tolstova E., Zaitseva N., Lokshina E., Abaseeva T., Bagirova N., Bardenikova S., Bogdanova N., Kuznetsov G., Mstislavskaya S., Ostroukhova I., Rychkova T., Serebrovskaya N., Striga E., Shavlokhova L., Shironina N., Nikonova M., Kuzina S., Efimova E., Belyaeva T.
|
| 卷 31, 编号 1 (2024) |
Erenumab – an antimigraine drug: experience of use |
|
|
Azimova Y., Skorobogatykh K., Osipova V., Korobkova D., Mamkhegov E., Galanina A., Guziy E., Frolova A.
|
| 卷 32, 编号 4 (2025) |
Erythema annulare centrifugum Darier |
|
|
Murakhovskaya E., Sysoeva T., Plakhova K., Asoskova A., Nefedova M.
|
| 卷 32, 编号 1 (2025) |
Stages of the study of mesenteric circulation disorders in the history of medicine |
|
|
Sidorova D., Gadzhimuradov R., Dibirov M., Khalidov O., Fomin V.
|
| 卷 31, 编号 5 (2024) |
Etiopathogenetic aspects of rosacea |
|
|
Ayupova K., Yusupova L.
|
| 卷 31, 编号 6 (2024) |
Efficacy of antihistamines in children with allergic rhinitis: the impact of polymorbidity |
|
|
Naumenko M., Petrov V., Shishimorov I., Magnitskaya O., Ponomareva Y.
|
| 卷 31, 编号 8 (2024) |
Efficacy of gosogliptin in the treatment of type 2 diabetes mellitus: a clinical case |
|
|
Smirnova E.
|
| 卷 30, 编号 13 (2023) |
Efficacy of dupilumab in children with alopecia areata and atopic dermatitis |
|
|
Dogov А., Murashkin N., Ambarchyan E.
|
| 卷 30, 编号 9/10 (2023) |
Efficacy and safety of the Actitropil in the treatment of reactive asthenia in young patients |
|
|
Vizilo T.
|
| 卷 32, 编号 6 (2025) |
Efficacy and safety of the drug Phosphogliv® URSO in patients with indications for oral litholysis: cholelithiasis and the pre-stone stage of the disease |
|
|
Nikitin I., Danilov A., Poromov A., Yankovaya T., Rybnikova I., Mikhailova O., Chuprakova N., Kudryavtseva A., Yunusova O., Makarova N., Shavalieva L., Demidova L., Kozlov V., Karimullina F., Fazylova Z.
|
| 卷 31, 编号 8 (2024) |
Efficacy and safety of the Russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data) |
|
|
Antsiferov M., Koteshkova O., Antsiferova D., Romashkina L., Golubeva Y.
|
| 卷 30, 编号 4/5 (2023) |
The effectiveness of intimate biorevitalization in the treatment of symptoms of vulvovaginal atrophy |
|
|
Saidova A., Dudkina A., Teterina T., Apolikhina I.
|
| 卷 30, 编号 4/5 (2023) |
Efficacy of intraovarian administration of platelet-rich plasma in infertility treatment programs using assisted reproductive technologies |
|
|
Fortygina Y., Kulakova E., Makarova N., Teterina T., Apolikhina I., Kalinina E.
|
| 卷 32, 编号 2 (2025) |
Efficiency of a fixed combination of insulin glargine and lixisenatide in everyday clinical practice |
|
|
Elsukova O., Nikitina E.
|
| 卷 30, 编号 11 (2023) |
Efficacy of the combination of pembrolizumab and axitinib in the treatment of renal cell carcinoma associated with chronic kidney disease |
|
|
Trofimtseva T., Yarovoy S., Gritskevich A., Baytman T.
|
| 卷 30, 编号 1/2 (2023) |
Effectiveness of oseltamivir in the prevention and treatment of influenza in children |
|
|
Belan E., Nikiforova E.
|
| 卷 30, 编号 4/5 (2023) |
Efficacy of pentahydroxyethylnaphthoquinone for the treatment and prevention of retinopathy of prematurity |
|
|
Feoktistova Y., Poddubniy E., Tyrtyshnikova A., Eliseeva E., Feoktistova E., Shulgina N.
|
| 卷 32, 编号 S1 (2025) |
Efficiency of using domestic enteral formula with metabolic action in children with cystic fibrosis |
|
|
Odinaeva N., Kondratieva E., Pilat T., Fatkhullina I., Zhekaite E., Kuznetsova Y.
|
| 卷 30, 编号 3 (2023) |
The effectiveness of the use of natural mineral water “Donat” in the complex therapy of lipid and carbohydrate metabolism disorders |
|
|
Mubarakshina O., Elizarova I., Cherenkova O.
|
| 卷 32, 编号 6 (2025) |
Efficiency of human placenta extract as a subcutaneous injection in patients with uterine factor of infertility in ART programs |
|
|
Kuzina S., Silantyeva E., Ovchinnikova M., Kutakova Y.
|
| 卷 31, 编号 7 (2024) |
Efficacy of ramucirumab in the second-line treatment of patients with disseminated gastric cancer in routine clinical practice in Russia (RAMSELGA observational study) |
|
|
Besova N., Titova T., Tryakin A., Artamonova E., Stroyakovsky D., Perminova E., Yukalchuk D., Ponomarenko D., Belyak N., Orlova R., Teletaeva G., Ratner E., Mochalova A., Zhabina A., Gamayunov S., Smolin A., Povyshev A., Andrievskikh M., Stilidi I.
|
| 卷 30, 编号 4/5 (2023) |
Effective methods of treatment of “thin” endometrium in patients of reproductive age |
|
|
Efendieva Z., Makovskaya D., Apolikhina I.
|
| 卷 32, 编号 2 (2025) |
Effects of ipragliflozin in patients with type 2 diabetes mellitus, arterial hypertension and left ventricular diastolic dysfunction in a short-term prospective study |
|
|
Safronova S., Druk I., Kanunnikova O., Korennova O., Podolnaya S., Klepatskaya T., Kalinina I.
|
| 601 - 650 的 650 信息 |
<< < 1 2 3 4 5 6 7 |
